Microscopic activity in ulcerative colitis: what does it mean?
Open Access
- 1 February 1991
- Vol. 32 (2) , 174-178
- https://doi.org/10.1136/gut.32.2.174
Abstract
To determine the prognostic importance of microscopic rectal inflammation we followed up 82 patients (aged 21 to 78 years, 44 men) with chronic quiescent ulcerative colitis over 12 months. At trial entry each patient underwent a rectal biopsy and sections were graded independently by two histopathologists. A chronic inflammatory cell infiltrate of varying severity was present in all biopsy specimens, and 58% had crypt architectural irregularities. In addition, 32% had evidence of acute inflammatory activity: 28% acute inflammatory cell infiltrate, 11% crypt abscesses, and 22% mucin depletion. Agreement between the two histopathologists for the presence of each of these features was 94% (90-98%). During the 12 month follow up 27 patients (33%) relapsed after a mean interval of 18 weeks (range 3-44 weeks). Relapse rates were unrelated to duration or extent of disease or to the type of maintenance drug treatment. In patients with an acute inflammatory cell infiltrate 52% relapsed, whereas in the absence of such an infiltrate only 25% relapsed (p = 0.02). Similarly, relapse rates were higher in the presence of crypt abscesses (78% v 27%, p less than 0.005), mucin depletion (56% v p less than 0.02), and breaches in the surface epithelium (75% v 31%, p = 0.1). The presence of a chronic inflammatory cell infiltrate or crypt architectural irregularities, however, bore no relation to the frequency of colitis relapse.Keywords
This publication has 19 references indexed in Scilit:
- Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazineAlimentary Pharmacology & Therapeutics, 1988
- Compliance to Therapy in Patients on a Maintenance Dose of SulfasalazineJournal of Clinical Gastroenterology, 1982
- Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitisDigestive Diseases and Sciences, 1982
- Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Gut, 1980
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- Rectal Biopsy in Inflammatory Bowel DiseaseNew England Journal of Medicine, 1972
- Persistence of mucosal abnormality in ulcerative colitis.Gut, 1966
- Sigmoidoscopy and cytology in the detection of microscopic disease of the rectal mucosa in ulcerative colitisGut, 1966
- Variation Between Observers in Describing Mucosal Appearances in ProctocolitisBMJ, 1964
- Biopsy Studies in Ulcerative ColitisBMJ, 1956